Skip to content
CJD Support New Zealand
  • About CJDSNZ
  • What is CJD?
  • Genetic Testing
  • Patient & Family Information
    • Post-mortem examinations
  • Helpful Links
  • News & Events
  • Contact Us
  • Toggle website search
Menu Close
  • About CJDSNZ
  • What is CJD?
  • Genetic Testing
  • Patient & Family Information
    • Post-mortem examinations
  • Helpful Links
  • News & Events
  • Contact Us
  • Toggle website search

News

Link to FB: Medical Research Future Fund (MRFF) Early to Mid-Career Researchers scheme

  • Post published:March 11, 2024
  • Post category:News/Research

From: Optometry and Vision Sciences at University of Melbourne Facebook page  - Dr Laura Ellett, Dr Pei Ying Lee and Dr Helen Jiaofor to secure the Medical Research Future Fund (MRFF) Early to Mid-Career Researchers…

Continue ReadingLink to FB: Medical Research Future Fund (MRFF) Early to Mid-Career Researchers scheme

Link to Article – Researchers uncovering early markers of prion disease in the eye

  • Post published:February 14, 2024
  • Post category:News/Research

From The Flory: Link: Researchers uncovering early markers of prion disease in the eye

Continue ReadingLink to Article – Researchers uncovering early markers of prion disease in the eye

Article: Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

  • Post published:January 31, 2024
  • Post category:News/Research

nature.com

Continue ReadingArticle: Iatrogenic Alzheimer’s disease in recipients of cadaveric pituitary-derived growth hormone

Link to blog: Prion Alliance – First details of Ionis trial disclosed

  • Post published:December 6, 2023
  • Post category:News/Prion Alliance/Research

Post by Eric Minikel from Prion Alliance Link - First details of Ionis trial disclosed

Continue ReadingLink to blog: Prion Alliance – First details of Ionis trial disclosed

Understanding Clinical Trials

  • Post published:December 2, 2023
  • Post category:News/Research

Please find below links to some general information on clinical trials which may be helpful in the lead-up to the commencement of clinical trials for prion disease: U.S. Department of…

Continue ReadingUnderstanding Clinical Trials

Link to article: Thirty years after my OE, how long will mad cow disease keep me from giving blood?

  • Post published:May 16, 2022
  • Post category:News

Link: Thirty years after my OE, how long will mad cow disease keep me from giving blood? from Stuff

Continue ReadingLink to article: Thirty years after my OE, how long will mad cow disease keep me from giving blood?

Link to Article: Concordance of CSF RT-QuIC across the European Creutzfeldt-Jakob Disease surveillance network

  • Post published:May 9, 2022
  • Post category:News/Research

Link: Concordance of CSF RT-QuIC across the European Creutzfeldt-Jakob Disease surveillance network from Doc Wire News. Article originally published National Library Medicine

Continue ReadingLink to Article: Concordance of CSF RT-QuIC across the European Creutzfeldt-Jakob Disease surveillance network

Article: Early Diagnosis of V180I Genetic Creutzfeldt-Jakob Disease at the Preserved Cognitive Function Stage

  • Post published:March 28, 2022
  • Post category:News/Research

Early Diagnosis of V180I Genetic Creutzfeldt-Jakob Disease at the Preserved Cognitive Function Stage from Cureus Journal of Medical Science

Continue ReadingArticle: Early Diagnosis of V180I Genetic Creutzfeldt-Jakob Disease at the Preserved Cognitive Function Stage

Podcast: In conversation with… John Collinge

  • Post published:March 28, 2022
  • Post category:News/Research

John Collinge (MRC Prion Unit, University College London, London, UK) discusses a first-in-human treatment programme to give PRN100, an anti-prion-protein monoclonal antibody, to patients with Creutzfeldt–Jakob disease; the report is published in…

Continue ReadingPodcast: In conversation with… John Collinge

Article: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme

  • Post published:March 28, 2022
  • Post category:News/Research

TLN_April2022_p342_354 (pdf) The Lancet Neurology April2022 p342_354 (online) from The Lancet Neurology

Continue ReadingArticle: Prion protein monoclonal antibody (PRN100) therapy for Creutzfeldt–Jakob disease: evaluation of a first-in-human treatment programme
  • Go to the previous page
  • 1
  • 2
  • 3
  • Go to the next page

Contact Info

  • contactus@cjdsupport.org.nz
  • National Toll Free Helpline:0800 225531

News & Events

  • Save the Date – 1st Annual National Information Meeting
  • Link to post: ION717 trial fully enrolled
  • Clinical Trial Update for Prion Diseases, December 2024
  • Link to article (update from Prion Alliance): Divalent siRNA for prion disease
© 2025 CJD Support New Zealand         Privacy Policy